Analysis of Recurrence of Intraductal Papilloma Treated With Vacuum-assisted Rotary Excision

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

106 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-06

Study Completion Date

2024-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To study the postoperative recurrence of intraductal papillomas (IDP) treated with ultrasound-guided vacuum-assisted excision (VAE), and to investigate the effect of different lesion characteristics on recurrence.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Endoscopic Extirpation of Benign Breast Tumors Using a Lateral Chest Wall Incision

NCT06472700

Endoscopic Breast Surgery Benign Breast Tumors

COMPLETED

Comparison of Microwave Ablation With Cryoablation for Breast Tumor

NCT03286413

Breast Tumor Microwave Ablation Cryoablation

UNKNOWN NA

A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery

NCT07071402

Breast Cancer (Early Breast Cancer)

RECRUITING NA

Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction

NCT01917578

Breast Cancer

UNKNOWN PHASE3

Evaluation of the Effectiveness and Safety of Laparoscopic Assisted Mastectomy With Preservation of Nipple and Areola, Immediate One-step Breast Reconstruction With Pectoral Muscle Prosthesis and Patch, and Simultaneous Autologous Fat Transplantation

NCT07037537

Breast Cancer Patients

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

106 patients with IDP with or without atypical ductal hyperplasia (ADH) treated with ultrasound-guided VAE at Zhongnan Hospital of Wuhan University from January 2020 to August 2024 were selected for the study, and the postoperative conditions of the patients were sorted out and followed up to analyze the characteristics of the lesions and to determine the relevant factors that affected the postoperative recurrence.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Surgery Benign Breast Tumors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

recurrent

Patients who relapsed after receiving ultrasound-guided vacuum-assisted rotary excision

enlarged resection

Intervention Type PROCEDURE

patients underwent secondary enlarged resection within 1 month after the diagnosis of IDP combined with ADH,

non-recurrent

Patients who did not relapsed after receiving ultrasound-guided vacuum-assisted rotary excision

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

enlarged resection

patients underwent secondary enlarged resection within 1 month after the diagnosis of IDP combined with ADH,

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

secondary enlarged resection

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* IDP was diagnosed pathologically after VAE treatment
* the tumor was a solitary lesion with the margin \>1cm from the nipple and the longest diameter of the tumor \<3cm
* it was not associated with other breast diseases

Exclusion Criteria

* previous ductal breast surgery
* abnormal coagulation function or taking anticoagulant drugs .recent or current use of hormonal or psychotropic drugs.

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No